201 related articles for article (PubMed ID: 15180783)
1. A case study in the treatment of dementia with Lewy bodies.
Kaufer DI
Acta Psychiatr Scand; 2004 Jul; 110(1):73-5; discussion 75-6. PubMed ID: 15180783
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Kaufer DI
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
4. Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
McKeith IG; Wesnes KA; Perry E; Ferrara R
Dement Geriatr Cogn Disord; 2004; 18(1):94-100. PubMed ID: 15087584
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
6. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
Alwahhabi FK
J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
[TBL] [Abstract][Full Text] [Related]
7. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
8. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
9. Successful use of donepezil for the treatment of dementia with Lewy bodies.
Rojas-Fernandez CH
Ann Pharmacother; 2001 Feb; 35(2):202-5. PubMed ID: 11215841
[TBL] [Abstract][Full Text] [Related]
10. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
[TBL] [Abstract][Full Text] [Related]
12. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Prasher VP
Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
14. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Moerkens RM; Dhondt AD
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
[No Abstract] [Full Text] [Related]
15. Diagnosis and treatment of dementia with Lewy bodies.
Josif S; Graham K
JAAPA; 2008 May; 21(5):22-6. PubMed ID: 18556885
[No Abstract] [Full Text] [Related]
16. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol JA
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
[No Abstract] [Full Text] [Related]
17. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
Auriacombe S; Pere JJ;
Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442
[No Abstract] [Full Text] [Related]
18. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T; Román G; Gauthier S
J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
[TBL] [Abstract][Full Text] [Related]
19. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
Aarsland D; Hutchinson M; Larsen JP
Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
[TBL] [Abstract][Full Text] [Related]
20. [Acetylcholinesterase inhibitors for dementia--an update].
Anghelescu I; Heuser I
MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]